NasdaqCM - Nasdaq Real Time Price USD
Anixa Biosciences, Inc. (ANIX)
2.7600
+0.0600
+(2.22%)
At close: April 25 at 4:00:02 PM EDT
2.7600
0.00
(0.00%)
After hours: April 25 at 4:05:10 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.7M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BASKIES ARNOLD M Director | Purchase at price 2.82 per share. | Direct | 14,100 | Jan 28, 2025 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.91 - 3.00 per share. | Direct | 8,820 | Jan 24, 2025 |
| TITTERTON LEWIS H JR Director | Purchase at price 3.01 per share. | Direct | 6,020 | Jan 22, 2025 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.59 per share. | Direct | 15,540 | Jan 21, 2025 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.57 per share. | Direct | 25,700 | Jan 17, 2025 |
| KUMAR AMIT Chief Executive Officer | Purchase at price 2.23 per share. | Direct | 95,890 | Jan 15, 2025 |
| CATELANI MICHAEL J President | Purchase at price 2.15 per share. | Direct | 19,971 | Jan 15, 2025 |
| TITTERTON LEWIS H JR Director | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 41,200 | Oct 22, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 3.06 - 3.23 per share. | Direct | 84,260 | Jul 31, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.81 - 3.03 per share. | Direct | 25,568 | Jul 26, 2024 |
| BASKIES ARNOLD M Director | Purchase at price 3.09 per share. | Direct | 15,450 | Jul 26, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.68 per share. | Direct | 10,720 | Jun 14, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.70 per share. | Direct | 1,094 | Jun 13, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.60 - 2.66 per share. | Direct | 19,749 | Jun 11, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 2.52 per share. | Direct | 27,060 | Jun 7, 2024 |
| KUMAR AMIT Chief Executive Officer | Purchase at price 2.41 per share. | Direct | 60,250 | Jun 7, 2024 |
| CATELANI MICHAEL J President | Purchase at price 2.40 per share. | Direct | 15,000 | Jun 7, 2024 |
| CATELANI MICHAEL J President | Stock Award(Grant) at price 2.52 per share. | Direct | 2,996 | Apr 30, 2024 |
| TITTERTON LEWIS H JR Director | Purchase at price 3.28 per share. | Direct | 49,230 | Apr 9, 2024 |
| KUMAR AMIT Chief Executive Officer | Purchase at price 3.22 per share. | Direct | 96,600 | Mar 15, 2024 |
| BASKIES ARNOLD M Director | Purchase at price 3.63 per share. | Direct | 36,300 | Mar 15, 2024 |
| CATELANI MICHAEL J President | Stock Award(Grant) at price 2.69 per share. | Direct | 3,005 | Oct 31, 2023 |
| TITTERTON LEWIS H JR Director | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 41,200 | Oct 10, 2023 |
| KUMAR AMIT Chief Executive Officer | Sale at price 3.57 per share. | Direct | 42,126 | Jul 31, 2023 |
| KUMAR AMIT Chief Executive Officer | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 103,000 | Jul 28, 2023 |
| TITTERTON LEWIS H JR Director | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 309,000 | Jul 27, 2023 |
| CATELANI MICHAEL J President | Purchase at price 3.64 per share. | Direct | 20,020 | Jul 20, 2023 |
| CATELANI MICHAEL J President | Stock Award(Grant) at price 3.47 per share. | Direct | 3,002 | Apr 28, 2023 |
Related Tickers
EQ Equillium, Inc.
0.4382
-4.74%
ANTX AN2 Therapeutics, Inc.
1.2500
-3.10%
MNOV MediciNova, Inc.
1.5600
+1.30%
DSGN Design Therapeutics, Inc.
3.8800
-8.49%
JSPRW Jasper Therapeutics, Inc.
0.0814
+34.55%
ADIL Adial Pharmaceuticals, Inc.
0.6850
-4.20%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
CDXS Codexis, Inc.
2.2600
-1.74%
RAPT RAPT Therapeutics, Inc.
0.8786
+0.48%
ATXS Astria Therapeutics, Inc.
5.17
-0.77%